DMA Diamedica Therapeutics

Greencastle Resources Ltd. (TSX VENTURE:VGN) ("Greencastle" or the "Company")
announces that the Company has completed a state-of-the-art detailed heli-borne
magnetic and EM geophysical survey to define targets for follow up exploration
on the company's Nechako property, where Greencastle has an option to acquire a
100% interest in the property, covering approximately 13,000 ha (28 claims), in
the Nechako Plateau region of BC. The property is located in the same general
area where Richfield Ventures Corp. is currently delineating a bulk tonnage gold
deposit at its Blackwater project.


Additionally, Greencastle has engaged Douglas McKay & Associates ("DMA") to
provide investor relations services for the company, subject to the approval of
the TSX Venture Exchange. DMA currently provides investor relations services to
Richfield Ventures Corp. under a contract that expires in April, 2011.


The agreement between the company and Douglas McKay & Associates provides for a
monthly retainer of $5,000 for a period of one year and an option grant of one
hundred and fifty thousand (150,000) options at an exercise price of $0.20, to
vest according to TSX-V policy.


Caution Concerning Forward-Looking Information

This news release includes certain "forward looking statements" within the
meaning of that phrase under Canadian securities laws. Without limitation,
statements regarding potential mineralization and resources, exploration
results, and future plans and objectives of the Company are forward looking
statements that involve various degrees of risk. Forward-looking statements
reflect management's current views with respect to possible future events and
conditions and, by their nature, are based on management's beliefs and
assumptions and subject to known and unknown risks and uncertainties, both
general and specific to the Company. Although the Company believes the
expectations expressed in such forward-looking statements are reasonable, such
statements are not guarantees of future performance and actual results or
developments may differ materially from those in our forward-looking statements.
The following are important factors that could cause the Company's actual
results to differ materially from those expressed or implied by such forward
looking statements: changes in the world wide price of commodities, general
market conditions, risks inherent in exploration, risks associated with
development, construction and mining operations, the uncertainty of future
profitability and the uncertainty of access to additional capital. Additional
information regarding the material factors and assumptions that were applied in
making these forward looking statements as well as the various risks and
uncertainties we face are described in greater detail in the "Risk Factors"
section of our annual and interim Management's Discussion and Analysis of our
financial results and other continuous disclosure documents and financial
statements we file with the Canadian securities regulatory authorities which are
available at www.sedar.com. The Company undertakes no obligation to update this
forward-looking information except as required by applicable law. The Company
relies on litigation protection for forward looking statements.

DiaMedica Inc. (TSXV:DMA)
Historical Stock Chart
From Jun 2024 to Jul 2024

DiaMedica Inc. (TSXV:DMA)
Historical Stock Chart
From Jul 2023 to Jul 2024